Building the foundation
The team established a healthcare-specific taxonomy and began assembling structured records on digital health ventures and ecosystems.
About Galen Growth
A decade of digital health intelligence
Founded in Singapore, Galen Growth brought structure, evidence, and comparability to a fast-moving global digital health market.
The beginning
From fragmented information to a research foundation
In November 2015, Galen Growth was founded around a shared observation: healthcare leaders were being asked to make digital health decisions without a consistent market definition or dependable evidence base.
Galen Growth began operating in 2016. Its early work focused on defining the digital health ecosystem, classifying ventures consistently, and documenting investment, evidence, partnership, and market activity across regions.
Milestones
How the research developed
Adding evidence and market signals
Research expanded beyond funding to include scientific evidence, commercial relationships, maturity, and other signals needed to compare companies and markets.
Publishing comparative analysis
Galen Growth produced global and regional research, the annual HealthTech 250, and analysis used by healthcare, investment, and innovation teams.
Tracking a maturing market
The research examined evidence quality, partnerships, exits, portfolio concentration, and the transition from digital health experimentation to operating infrastructure.
Galen Growth ceased operations on 31 October 2026. HealthTech Alpha is no longer available. This archive keeps our published research freely available until 31 December 2026. Reports reflect the data at the time of publication and will not be updated.
The archive
Preserving the research record
The Galen Growth archive preserves the company's published research, analysis, definitions, annual market selections, and historical record for continued reference.
For archive-related questions, contact info@galengrowth.com.